A Photochemical Route to Optically Active Hexahydro-4H-furopyranol, a High-Affinity P2 Ligand for HIV-1 Protease Inhibitors

被引:3
作者
Ghosh, Arun K. [1 ]
Robinson, William L.
机构
[1] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA
基金
美国国家卫生研究院;
关键词
RESISTANT; PHOTOADDITION; DARUNAVIR;
D O I
10.1021/acs.joc.9b01361
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
We describe here the syntheses of optically pure (3aS,4S,7aR)-hexahydro-4H-furo[2,3-b]pyran-4-ol and (3aR,4R,7aS)-hexahydro-4H-furo [2,3-b]pyran-4-ol. These stereochemically defined heterocycles are important high-affinity P2 ligands for a variety of highly potent HIV-1 protease inhibitors. The key steps involve an efficient Paterno-Buchi [2 + 2] photocycloaddition, catalytic hydrogenation, acid-catalyzed cyclization to form the racemic ligand alcohol, and an enzymatic resolution with immobilized Amano Lipase PS-30. Optically active ligands (-)-6 and (+)-6 were obtained with high enantiomeric purity. Enantiomer (-)-6 has been converted to potent HIV-1 protease inhibitor 3.
引用
收藏
页码:9801 / 9805
页数:5
相关论文
共 28 条
[1]   C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir [J].
Aoki, Manabu ;
Hayashi, Hironori ;
Yedidi, Ravikiran S. ;
Martyr, Cuthbert D. ;
Takamatsu, Yuki ;
Aoki-Ogata, Hiromi ;
Nakamura, Teruya ;
Nakata, Hirotomo ;
Das, Debananda ;
Yamagata, Yuriko ;
Ghosh, Arun K. ;
Mitsuya, Hiroaki .
JOURNAL OF VIROLOGY, 2016, 90 (05) :2180-2194
[2]   The Paterno-Buchi reaction on furan derivatives [J].
D'Auria, M ;
Emanuele, L ;
Racioppi, R ;
Romaniello, G .
CURRENT ORGANIC CHEMISTRY, 2003, 7 (14) :1443-1459
[3]   Oxetane Synthesis through the Paterno-Buchi Reaction [J].
D'Auria, Maurizio ;
Racioppi, Rocco .
MOLECULES, 2013, 18 (09) :11384-11428
[4]  
de Béthune MP, 2011, ANTIVIRAL DRUGS: FROM BASIC DISCOVERY THROUGH CLINICAL TRIALS, P31
[5]  
Doan B. D., 2002, U. S. Patent, Patent No. 7145024
[6]   Current status and challenges of antiretroviral research and therapy [J].
Este, Jose A. ;
Cihlar, Tomas .
ANTIVIRAL RESEARCH, 2010, 85 (01) :25-33
[7]   Ending the HIV-AIDS Pandemic - Follow the Science [J].
Fauci, Anthony S. ;
Marston, Hilary D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23) :2197-2199
[8]  
Ghosh A.K., 2014, Structure-Based Design of Drugs and other Bioactive Molecules: Tools and Strategies
[9]  
GHOSH AK, 2006, CHEMMEDCHEM, V1, P939, DOI DOI 10.1002/CMDC.200600103
[10]   Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV [J].
Ghosh, Arun K. ;
Dawson, Zachary L. ;
Mitsuya, Hiroaki .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) :7576-7580